Langley Wealth Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Langley Wealth Management's PFE Position: Q3 2026 in Review
Langley Wealth Management increased its Pfizer (PFE) stake by 0.09% in Q3 2026, buying an estimated $1.25K and bringing the position to 54,838 shares worth $1.56M. The position accounts for 1.53% of the portfolio, ranked #18.
Langley Wealth Management first reported a position in PFE in Q2 2026 and has held it in 2 quarters since. 2,556 funds tracked by Wall St. Rank hold PFE as of Q3 2026.
- Langley Wealth Management held 54,838 shares of Pfizer worth $1.56M as of Q3 2026.
- Langley Wealth Management bought 47 Pfizer shares in Q3 2026, an estimated $1.25K.
- Pfizer made up 1.53% of Langley Wealth Management's portfolio in Q3 2026, its #18 holding.
- Langley Wealth Management first reported a position in Pfizer in Q2 2026 and has held it in 2 quarters since.
- 2,556 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.
Based on Langley Wealth Management's 13F filing for Q3 2026, filed 4 Nov 2026.